214 related articles for article (PubMed ID: 35509981)
21. Prognostic value of ferroptosis-related genes in patients with lung adenocarcinoma.
Zhu G; Huang H; Xu S; Shi R; Gao Z; Lei X; Zhu S; Zhou N; Zu L; Mello RA; Chen J; Xu S
Thorac Cancer; 2021 Jun; 12(12):1890-1899. PubMed ID: 33979897
[TBL] [Abstract][Full Text] [Related]
22. Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
Ren Z; Hu M; Wang Z; Ge J; Zhou X; Zhang G; Zheng H
Front Genet; 2021; 12():672904. PubMed ID: 34434214
[TBL] [Abstract][Full Text] [Related]
23. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification.
Gao C; Kong N; Zhang F; Tang T; Li J; Ding H; Sun Z; Wu L; Xu M
BMC Med Genomics; 2022 Jan; 15(1):15. PubMed ID: 35093068
[TBL] [Abstract][Full Text] [Related]
24. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
[TBL] [Abstract][Full Text] [Related]
25. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
26. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
28. Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma.
Ye C; Lu Y; Yuan Z; Mi M; Qi L; Yuan Y; Weng S
Front Genet; 2022; 13():922914. PubMed ID: 36267413
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
30. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients.
Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324
[TBL] [Abstract][Full Text] [Related]
31. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinoma.
Yin Y; He M; Huang Y; Xie X
BMC Immunol; 2023 Oct; 24(1):37. PubMed ID: 37817081
[TBL] [Abstract][Full Text] [Related]
33. SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma.
Liu XS; Zhang Y; Ming X; Hu J; Chen XL; Wang YL; Zhang YH; Gao Y; Pei ZJ
Aging (Albany NY); 2024 Jan; 16(1):779-798. PubMed ID: 38217547
[TBL] [Abstract][Full Text] [Related]
34. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.
Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J
Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954
[TBL] [Abstract][Full Text] [Related]
35. Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines.
Chen Y; Zhang C; Li Y; Tan X; Li W; Tan S; Liu G
Sci Rep; 2024 Feb; 14(1):3219. PubMed ID: 38331967
[TBL] [Abstract][Full Text] [Related]
36. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
[TBL] [Abstract][Full Text] [Related]
37. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
Uddin MN; Akter R; Li M; Abdelrahman Z
Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
[TBL] [Abstract][Full Text] [Related]
38. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
40. A Prognostic 14-Gene Expression Signature for Lung Adenocarcinoma: A Study Based on TCGA Data Mining.
Liu J; Hou S; Wang J; Chai Z; Hong X; Zhao T; Sun Z; Bai L; Gao H; Gao J; Chen G
Oxid Med Cell Longev; 2020; 2020():8847226. PubMed ID: 33414898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
